By Professor Don Edward Smith

Conference Papers

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27403

Chan DJ; Ray J; Mcnally L; Batterham M; Smith DE, 2008, 'Correlation Between HIV-1 RNA Load in Blood and Seminal Plasma Depending on Antiretroviral Treatment Status, Regimen and Penetration of Semen by Antiretroviral Drugs', in Current HIV Research, Bentham Science Publishing Ltd, Hilversum, Netherlands, pp. 477 - 484, presented at Current HIV Research

Grey PA; Vizzard J; Smith DE; Cooper DA, 1997, 'Aggressive therapy does not appear to shorten the duration of primary HIV infection (PHI) symptoms.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997

Clarkson J; French FA; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Cooper DA; Stewart GA; Benson EM, 1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997

Bloch M; Kelleher AD; Smith DE; Grey PA; Zaunders J; Cooper DA, 1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, 11 October 1997 - 15 October 1997

Kelleher AD; Bloch M; Smith DE; Grey PA; Cunningham PH; Zaunders J; Cooper DA, 1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 29 September 1997 - 01 October 1997

Smith DE; Bloch M; Grey PA; Cunningham PH; Zaunders J; Kelleher AD; Cooper DA, 1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, 25 June 1997 - 29 June 1997

Kelleher AD; Walker AC; Jaramillo AB; Roggensack M; Smith DE; Gow I; Cooper DA, 1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA

Smith DE, 1997, 'Fourth Conference on retroviruses an dopportunistic infections', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA

Kelleher AD; Smith DE; Cooper DA; Walker AC; Gow I; Patou G, 1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

Smith DE; Law MG; Workman C; Newman AS, 1996, 'Aggressive use of combination antiretroviral by Australian General Practitioners', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 43 - 43, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

Fagan D; Phillips SE; Smith DE; Duncombe CJ; Catchpole BR; Buchanan AP; Roth N, 1996, 'An observational study of antiretroviral treatment in HIV-infected patients attending General Practices in Australia in 1995', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 46 - 46, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

Smith DE, 1996, 'Clinical and survival benefit of 3TC combination therapy in HIV-1 infection: interim results of the CAESAR study', in Australian Society for HIV Medicine 8th National Conference, Sydney, pp. 103a - 103a, presented at Australian Society for HIV Medicine 8th National Conference, Sydney

Workman C; Downie C; Smith DE; Sutherland DA; Michelmore H; Dyer W; Shen J; Sullivan JS, 1996, 'Combination therapies in primary HIV infectin', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. OP1.1 - OP1.1, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

Smith DE; Boag F; Colebunders R; Weller IV; Tchamouroff S; Weber J; Gow I; Patou G; Cooper DA, 1996, 'Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection does not alter CD4 decline', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 0P6.5 - 0P6.5, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

Back to profile page